BME

$46.542.62%-1.25

Blackrock Health Sciences Trust (BME)

Blackrock Health Sciences Trust Stock (BME) Forecast

The Blackrock Health Sciences Trust (BME) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $46.57, representing a +0.06% increase from the current price of $46.54. The highest analyst price target is $48.13, and the lowest is $45.01.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.

12-Month BME Price Target

Average 43.36 (-6.83% Upside)

Is Blackrock Health Sciences Trust (BME) A Buy Now?

Oscillators

Name	Value	Action
RSI(14)	58.33	Neutral
STOCH(9,6)	79.97	Neutral
STOCHRSI(14)	33.70	Neutral
MACD(12,26)	0.72	Buy
ADX(14)	23.15	Neutral
William %R	-38.34	Neutral
CCI(14)	57.86	Neutral

Buy: 1 · Sell: 0 · Neutral: 6Summary: Neutral

Moving Averages

Period	Simple	Exponential
MA10	46.33 Buy	46.42 Buy
MA20	45.48 Buy	45.77 Buy
MA50	44.91 Buy	44.96 Buy
MA100	44.09 Buy	44.00 Buy
MA200	42.18 Buy	42.47 Buy

Buy: 10 · Sell: 0 · Neutral: 0Summary: Buy

According to our latest analysis, BME could be considered a Strong Buy, with 17 technical analysis indicators signaling 11 Buy signals, 0 signaling Sell signals and 6 Neutral signals. This might be a good time to open fresh positions on BME, as trading bullish markets is always a lot easier

RSI (Relative Strength Index): The RSI(14) value of 58.33 indicates that BME is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
STOCH (Stochastic Oscillator): The STOCH value of 79.97 indicates that BME is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 33.70 indicates that BME is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
ADX (Average Directional Index): The ADX value of 23.15 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
CCI (Commodity Channel Index): A CCI(14) value of 57.86 indicates that BME is still overbought but not to an extreme extent.

Long-term BME price forecast for 2026, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Blackrock Health Sciences Trust financial reports and earnings history, Blackrock Health Sciences Trust (BME) stock could reach $42.37 by 2030, $42.05 by 2040 and $44.15 by 2050. See the projected annual prices until 2050 of the Blackrock Health Sciences Trust stock below:

Blackrock Health Sciences Trust (BME) is expected to reach an average price of $38.87 in 2035, with a high prediction of $42.21 and a low estimate of $37.46. This indicates an -16.48% change from the last recorded price of $46.54.
Blackrock Health Sciences Trust (BME) stock is projected to chart a bullish course in 2040, with an average price target of $38.80, representing an -16.63% change from its current level. The forecast ranges from a conservative $34.72 to a sky-high $42.05.
Our analysts predict Blackrock Health Sciences Trust (BME) to change -17.96% by 2045, soaring from $37.38 to an average price of $38.18, potentially reaching $44.40. While $37.38 is the low estimate, the potential upside is significant.
Blackrock Health Sciences Trust (BME) stock is expected to climb by 2050, reaching an average of $40.40, a -13.19% change from its current level. However, a wide range of estimates exists, with high and low targets of $44.15 and $36.92, respectively, highlighting the market's uncertainty.

Blackrock Health Sciences Trust Stock (BME) Year by Year Forecast

Blackrock Health Sciences Trust Stock (BME) Price Forecast for 2026

The predicted value for Blackrock Health Sciences Trust (BME) in 2026 is set at an average of $43.30. Estimates vary from a peak of $48.51 to a trough of $37.51, indicating an -6.96% surge from the present price of $46.54.

Month	Average	Low	High	Change from today's price
December, 2026	$48.03	$45.01	$48.13	+3.20%

Blackrock Health Sciences Trust Stock (BME) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Blackrock Health Sciences Trust (BME) is $42.84, with a high forecast of $48.72 and a low forecast of $38.00. This indicates an -7.95% decrease from the last price of $46.54.

Month	Average	Low	High	Change from today's price
January, 2027	$43.90	$43.86	$48.72	-5.67%
February, 2027	$43.71	$42.02	$45.62	-6.08%
March, 2027	$41.57	$40.48	$44.16	-10.68%
April, 2027	$46.04	$41.04	$46.45	-1.07%
May, 2027	$42.63	$42.03	$46.77	-8.40%
June, 2027	$43.51	$40.72	$44.14	-6.51%
July, 2027	$42.45	$39.24	$44.16	-8.79%
August, 2027	$42.31	$41.51	$44.12	-9.09%
September, 2027	$43.06	$42.35	$44.80	-7.48%
October, 2027	$42.62	$40.63	$43.27	-8.42%
November, 2027	$38.78	$38.00	$43.31	-16.67%
December, 2027	$43.51	$38.10	$43.73	-6.51%

Blackrock Health Sciences Trust Stock (BME) Price Forecast for 2028

In 2028, Blackrock Health Sciences Trust (BME) is projected to reach an average price of $40.96, with a high projection of $45.23 and a low estimate of $38.78. This indicates an -11.99% fall from the last price of $46.54.

Month	Average	Low	High	Change from today's price
January, 2028	$44.30	$42.24	$45.23	-4.81%
February, 2028	$43.31	$42.11	$44.77	-6.94%
March, 2028	$42.90	$41.89	$43.70	-7.82%
April, 2028	$42.38	$42.05	$43.58	-8.94%
May, 2028	$39.07	$38.96	$43.13	-16.05%
June, 2028	$41.61	$39.05	$42.49	-10.59%
July, 2028	$40.56	$40.31	$42.93	-12.85%
August, 2028	$39.98	$39.12	$40.86	-14.09%
September, 2028	$39.38	$39.38	$40.53	-15.38%
October, 2028	$39.48	$39.38	$40.73	-15.17%
November, 2028	$39.69	$38.99	$40.08	-14.72%
December, 2028	$38.88	$38.78	$39.97	-16.46%

Blackrock Health Sciences Trust Stock (BME) Price Forecast for 2029

The 2029 price forecast for Blackrock Health Sciences Trust Stock (BME) is $39.78 on average, with a high prediction of $42.59 and a low estimate of $35.26. This represents an -14.53% decrease from the previous price of $46.54.

Month	Average	Low	High	Change from today's price
January, 2029	$35.26	$35.26	$39.41	-24.24%
February, 2029	$37.24	$35.28	$37.82	-19.98%
March, 2029	$38.28	$37.15	$38.49	-17.75%
April, 2029	$42.33	$38.33	$42.59	-9.04%
May, 2029	$41.31	$40.42	$42.23	-11.24%
June, 2029	$41.75	$41.02	$42.48	-10.29%
July, 2029	$41.17	$40.46	$42.33	-11.54%
August, 2029	$38.79	$38.16	$41.28	-16.65%
September, 2029	$39.88	$38.79	$40.04	-14.31%
October, 2029	$39.37	$39.05	$40.61	-15.40%
November, 2029	$40.86	$39.44	$41.72	-12.20%
December, 2029	$41.11	$39.61	$41.47	-11.67%

Blackrock Health Sciences Trust Stock (BME) Price Forecast for 2030

Blackrock Health Sciences Trust Stock (BME) is expected to reach an average price of $38.55 in 2030, with a high forecast of $42.37 and a low forecast of $33.91. This signifies an -17.17% decrease from the last price of $46.54.

Month	Average	Low	High	Change from today's price
January, 2030	$41.99	$40.83	$42.37	-9.77%
February, 2030	$41.30	$40.88	$42.11	-11.26%
March, 2030	$39.66	$39.66	$42.03	-14.78%
April, 2030	$39.64	$37.73	$41.09	-14.82%
May, 2030	$38.05	$36.60	$39.72	-18.24%
June, 2030	$39.19	$37.08	$39.34	-15.79%
July, 2030	$39.96	$39.25	$40.93	-14.14%
August, 2030	$38.63	$37.71	$40.37	-16.99%
September, 2030	$35.73	$33.91	$39.16	-23.23%
October, 2030	$35.93	$35.01	$37.38	-22.80%
November, 2030	$36.13	$34.66	$36.55	-22.37%
December, 2030	$36.39	$35.03	$36.73	-21.81%

Similar to BME